BIOVERATIV INC. Selling, General and Administrative Expense
BIOVERATIV INC. reported Selling, General and Administrative Expense of $217.10 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2018-02-14
- BIOVERATIV INC. selling, general and administrative expense for the quarter ending 2017-12-31 was $56.60M, a 71.52% increase year-over-year.
- BIOVERATIV INC. selling, general and administrative expense for the quarter ending 2017-09-30 was $52.20M, a 46.22% increase year-over-year.
- BIOVERATIV INC. selling, general and administrative expense for the quarter ending 2017-06-30 was $61.30M, a 55.98% increase year-over-year.
- BIOVERATIV INC. selling, general and administrative expense for the quarter ending 2017-03-31 was $47.00M, a 20.51% increase year-over-year.
- BIOVERATIV INC. selling, general and administrative expense for fiscal 2017 was $217.10M, a 47.69% increase from fiscal 2016.
- BIOVERATIV INC. selling, general and administrative expense for fiscal 2016 was $147.00M, a 14.78% decline from fiscal 2015.
- BIOVERATIV INC. selling, general and administrative expense for fiscal 2015 was $172.50M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2017-12-31 | $56.60M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-14 | $108.80M derived: sum of 2 quarters · filed 2018-02-14 | $170.10M derived: sum of 3 quarters · filed 2018-02-14 | $217.10M 10-K · filed 2018-02-14 |
| 2017-09-30 | $52.20M 10-Q · filed 2017-10-27 | $113.50M derived: sum of 2 quarters · filed 2017-10-27 | $160.50M 10-Q · filed 2017-10-27 | $193.50M derived: sum of 4 quarters · filed 2018-02-14 |
| 2017-06-30 | $61.30M 10-Q · filed 2017-08-03 | $108.30M 10-Q · filed 2017-08-03 | $141.30M derived: sum of 3 quarters · filed 2018-02-14 | $177.00M derived: sum of 4 quarters · filed 2018-02-14 |
| 2017-03-31 | $47.00M 10-Q · filed 2017-05-12 | $80.00M derived: sum of 2 quarters · filed 2018-02-14 | $115.70M derived: sum of 3 quarters · filed 2018-02-14 | $155.00M derived: sum of 4 quarters · filed 2018-02-14 |
| 2016-12-31 | $33.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-14 | $68.70M derived: sum of 2 quarters · filed 2018-02-14 | $108.00M derived: sum of 3 quarters · filed 2018-02-14 | $147.00M 10-K · filed 2018-02-14 |
| 2016-09-30 | $35.70M 10-Q · filed 2017-10-27 | $75.00M derived: sum of 2 quarters · filed 2017-10-27 | $114.00M 10-Q · filed 2017-10-27 | |
| 2016-06-30 | $39.30M 10-Q · filed 2017-08-03 | $78.30M 10-Q · filed 2017-08-03 | ||
| 2016-03-31 | $39.00M 10-Q · filed 2017-05-12 | |||
| 2015-12-31 | $172.50M 10-K · filed 2018-02-14 |